RLX
Product Specifications
CAS Number
4425-23-4
Target
Others, PI3K, Akt, FOXO
Related Pathways
Others, Apoptosis, Cytoskeletal Signaling, PI3K/Akt/mTOR signaling
Purity
0.9981
Bioactivity
RLX (PD 139530) is a PI3K/Akt/FoxO3a signal inhibitor with anticancer activity against tumour cell lines such as colon cancer, inducing sub-G1 arrest and mitochondrial potential loss, thereby inhibiting tumour growth. RLX also exhibits antitussive and anti-asthmatic activity, reducing eosinophils and total lymphocytes in bronchoalveolar lavage (BAL) fluid, and exhibits toxicity toward A549 cells.
Smiles
O=C1C=2C=CC=CC2N=C3N1CCCCC3
Molecular Formula
C13H14N2O
Molecular Weight
214.26
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6226984-01 0.1 mL
CGRRF1 (Cell Growth Regulator with Ring Finger Domain 1, CGR19, RNF197) (MaxLight 650)
Sign In for Pricing
View Details MBS6226984-02 5x 0.1 mL
CGRRF1 (Cell Growth Regulator with Ring Finger Domain 1, CGR19, RNF197) (MaxLight 650)
Sign In for Pricing
View Details